Kappa‐opioid receptor‐mediated thermal analgesia evoked by the intrathecal administration of the chemokine CCL1 in mice

The chemokine CC motif ligand 1 (CCL1) participates in immune cell recruitment and, as other chemokines, is also involved in nociceptive processing. In contrast with previous reports indicating its participation in allodynia and cold hypernociception when spinally administered, its ability to evoke heat thermal analgesia, mediated by circulating leukocytes and endocannabinoids, after systemic administration has recently been reported.

[1]  Yongxiang Wang,et al.  Bulleyaconitine A Inhibits Visceral Nociception and Spinal Synaptic Plasticity through Stimulation of Microglial Release of Dynorphin A , 2020, Neural plasticity.

[2]  Yong-Jing Gao,et al.  Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential. , 2020, Pharmacology & therapeutics.

[3]  Yi-ze Li,et al.  Spinal CCL1/CCR8 regulates phosphorylation of GluA1-containing AMPA receptor in postoperative pain after tibial fracture and orthopedic surgery in mice , 2020, Neuroscience Research.

[4]  Yongxiang Wang,et al.  Bulleyaconitine A Exerts Antianxiety and Antivisceral Hypersensitivity Effects , 2020, Frontiers in Pharmacology.

[5]  Zhiheng Chen,et al.  Dynorphin activation of kappa opioid receptor promotes microglial polarization toward M2 phenotype via TLR4/NF-κB pathway , 2020, Cell & Bioscience.

[6]  A. Gutiérrez-Fernández,et al.  Dual dose-related effects evoked by CCL4 on thermal nociception after gene delivery or exogenous administration in mice. , 2020, Biochemical pharmacology.

[7]  Y. Yamaguchi,et al.  Gadolinium causes M1 and M2 microglial apoptosis after intracerebral haemorrhage and exerts acute neuroprotective effects , 2020, The Journal of pharmacy and pharmacology.

[8]  M. García-Domínguez,et al.  The Systemic Administration of the Chemokine CCL1 Evokes Thermal Analgesia in Mice Through the Activation of the Endocannabinoid System , 2019, Cellular and Molecular Neurobiology.

[9]  Jiao Guo,et al.  M2b macrophage polarization and its roles in diseases , 2018, Journal of leukocyte biology.

[10]  Y. Qadri,et al.  Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain , 2018, Neuron.

[11]  R. Cernuda-Cernuda,et al.  The Chemokine CCL4 (MIP-1β) Evokes Antinociceptive Effects in Mice: a Role for CD4+ Lymphocytes and Met-Enkephalin , 2018, Molecular Neurobiology.

[12]  M. Tsuda,et al.  Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential , 2018, Nature Reviews Neuroscience.

[13]  C. Pert,et al.  Neuropathic pain inhibitor, RAP-103, is a potent inhibitor of microglial CCL1/CCR8 , 2017, Neurochemistry International.

[14]  A. Piotrowska,et al.  Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target – Evidence from a mouse diabetic neuropathy model , 2017, International immunopharmacology.

[15]  L. Ferreira,et al.  Anti-Inflammatory Strategy for M2 Microglial Polarization Using Retinoic Acid-Loaded Nanoparticles , 2017, Mediators of inflammation.

[16]  R. Cernuda-Cernuda,et al.  Hyperalgesic and hypoalgesic mechanisms evoked by the acute administration of CCL5 in mice , 2017, Brain, Behavior, and Immunity.

[17]  Yongxiang Wang,et al.  Molecular signaling underlying bulleyaconitine A (BAA)-induced microglial expression of prodynorphin , 2017, Scientific Reports.

[18]  Yongxiang Wang,et al.  Aconitum-Derived Bulleyaconitine A Exhibits Antihypersensitivity Through Direct Stimulating Dynorphin A Expression in Spinal Microglia. , 2016, The journal of pain : official journal of the American Pain Society.

[19]  C. McPherson,et al.  Microglial M1/M2 polarization and metabolic states , 2016, British journal of pharmacology.

[20]  A. Piotrowska,et al.  Parthenolide Relieves Pain and Promotes M2 Microglia/Macrophage Polarization in Rat Model of Neuropathy , 2015, Neural plasticity.

[21]  Y. Iwakura,et al.  Chemokine Receptor CCR8 Is Required for Lipopolysaccharide-Triggered Cytokine Production in Mouse Peritoneal Macrophages , 2014, PloS one.

[22]  R. Ji,et al.  Microglia and Spinal Cord Synaptic Plasticity in Persistent Pain , 2013, Neural plasticity.

[23]  M. Noda,et al.  Effects of chemokine (C-C motif) ligand 1 on microglial function. , 2013, Biochemical and biophysical research communications.

[24]  M. Kido,et al.  CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury , 2013, Cell Death and Disease.

[25]  B. Fitzsimmons,et al.  Spinal astrocytes produce and secrete dynorphin neuropeptides , 2013, Neuropeptides.

[26]  N. Kiguchi,et al.  CC‐chemokine ligand 4/macrophage inflammatory protein‐1β participates in the induction of neuropathic pain after peripheral nerve injury , 2012, European journal of pain.

[27]  Tamara Boto,et al.  Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice. , 2011, European journal of pharmacology.

[28]  A. Hidalgo,et al.  Involvement of glutamate NMDA and AMPA receptors, glial cells and IL-1β in the spinal hyperalgesia evoked by the chemokine CCL2 in mice , 2011, Neuroscience Letters.

[29]  Y. Day,et al.  Inflammation Confers Dual Effects on Nociceptive Processing in Chronic Neuropathic Pain Model , 2011, Anesthesiology.

[30]  N. Murphy,et al.  Enkephalins, dynorphins, and β‐endorphin in the rat dorsal horn: An immunofluorescence colocalization study , 2009, The Journal of comparative neurology.

[31]  H. Rittner,et al.  The other side of the medal: How chemokines promote analgesia , 2008, Neuroscience Letters.

[32]  F. Schaefer,et al.  Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. , 2007, The American journal of pathology.

[33]  Chongguang Chen,et al.  Dynorphin peptides differentially regulate the human κ opioid receptor , 2007 .

[34]  Yong Liu,et al.  CCR7, CCR8, CCR9 and CCR10 in the mouse hippocampal CA1 area and the dentate gyrus during and after pilocarpine‐induced status epilepticus , 2007, Journal of neurochemistry.

[35]  H. Rittner,et al.  Chemokines and pain. , 2006, Current opinion in investigational drugs.

[36]  R. Coggeshall Fos, nociception and the dorsal horn , 2005, Progress in Neurobiology.

[37]  H. Rittner,et al.  Leukocytes in the regulation of pain and analgesia , 2005, Journal of leukocyte biology.

[38]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[39]  A. Iellem,et al.  Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells , 2001, The Journal of experimental medicine.

[40]  M. Baggiolini,et al.  Identification of CCR8, the Receptor for the Human CC Chemokine I-309* , 1997, The Journal of Biological Chemistry.

[41]  T. Bonner,et al.  Brief Definitive Report Identification of CCR8: A Human Monocyte and Thymus Receptor for the CC Chemokine I-309 , 2022 .

[42]  R. Leak,et al.  Microglial and macrophage polarization—new prospects for brain repair , 2015, Nature Reviews Neurology.

[43]  W. Pardridge,et al.  Blood-brain barrier delivery. , 2007, Drug discovery today.

[44]  Chongguang Chen,et al.  Dynorphin peptides differentially regulate the human kappa opioid receptor. , 2007, Life sciences.

[45]  H. Akil,et al.  The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. , 1995, Brain research.